$Defiance Daily Target 2X Long NVO ETF(NVOX)$
$Novo-Nordisk A/S(NVO)$
BEIJING, June 16 (Reuters) - Novo Nordisk NOVOb.CO plans to seek Chinese regulatory approval for its weight-loss pill "very soon," CEO Mike Doustdar said Tuesday, in a move to catch up with rival Eli Lilly LLY.N in the world's second-largest pharmaceutical market.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- WeLian·06-18 19:47Dead stock !LikeReport